Annual report pursuant to Section 13 and 15(d)

Intangible Assets and Goodwill

v3.19.3.a.u2
Intangible Assets and Goodwill
12 Months Ended
Sep. 30, 2019
Intangible Assets and Goodwill [Abstract]  
Intangible Assets and Goodwill

Note 8 –Intangible Assets and Goodwill



Intangible Assets



Intangible assets acquired in the APP Acquisition included IPR&D, developed technology consisting of PREBOOST®  medicated wipes for the treatment of premature ejaculation, and covenants not-to-compete.  



The gross carrying amounts and net book value of intangible assets are as follows at September 30, 2019





 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 



Gross Carrying

 

Accumulated

 

Net Book



Amount

 

Amortization

 

Value

Intangible assets with finite lives:

 

 

 

 

 

 

 

 

Developed technology - PREBOOST®

$

2,400,000 

 

$

523,172 

 

$

1,876,828 

Covenants not-to-compete

 

500,000 

 

 

208,333 

 

 

291,667 

Total intangible assets with finite lives

 

2,900,000 

 

 

731,505 

 

 

2,168,495 

Acquired in-process research and development assets

 

18,000,000 

 

 

 —

 

 

18,000,000 

Total intangible assets

$

20,900,000 

 

$

731,505 

 

$

20,168,495 



The gross carrying amounts and net book value of intangible assets are as follows at September 30, 2018:





 

 

 

 

 

 

 

 



Gross Carrying

 

Accumulated

 

Net Book



Amount

 

Amortization

 

Value

Intangible assets with finite lives:

 

 

 

 

 

 

 

 

Developed technology - PREBOOST®

$

2,400,000 

 

$

285,366 

 

$

2,114,634 

Covenants not-to-compete

 

500,000 

 

 

136,905 

 

 

363,095 

Total intangible assets with finite lives

 

2,900,000 

 

 

422,271 

 

 

2,477,729 

Acquired in-process research and development assets

 

18,000,000 

 

 

 —

 

 

18,000,000 

Total intangible assets

$

20,900,000 

 

$

422,271 

 

$

20,477,729 



Amortization is recorded over the projected related revenue stream for the PREBOOST® developed technology over 10 years and on a straight-line basis over seven years for the covenants not-to-compete. The amortization expense is recorded in selling, general and administrative expenses in the accompanying consolidated statements of operations.



Amortization expense was approximately $309,000 and $275,000, for the years ended September 30, 2019 and 2018, respectively. Based on finite-lived intangible assets recorded as of September 30, 2019, the estimated future amortization expense is as follows:





 

 



Estimated

Year Ending September 30,

Amortization Expense

2020

$

316,368 

2021

 

323,706 

2022

 

331,316 

2023

 

339,062 

2024

 

281,603 

Thereafter

 

576,440 

Total

$

2,168,495 

 

Goodwill



The carrying amount of goodwill at September 30, 2019 and 2018 was $6.9 million. There was no change in the balance during the years ended September 30, 2019 and 2018.